Betrixaban for Deep Venous Thrombosis Prevention in a Patient with End-Stage Renal Disease on Intermittent Hemodialysis
Journal of Biosciences and Medicines · 2026 · 14 (05) · 407-413
DOI: 10.4236/jbm.2026.145027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biosciences and Medicines, 2026. Verfasst von Victoria M Stevens und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, University of Colorado Hospital, Aurora, CO, USA. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, University of Colorado Hospital, Aurora, CO, USA.
- Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA.
ORCID-Profile: Victoria M Stevens, Craig J Furnish, Tyree H Kiser
Förderung
- NCATS NIH HHS
Zitieren
APA
Stevens, V. M., Furnish, C. J., & Kiser, T. H. (2026). Betrixaban for Deep Venous Thrombosis Prevention in a Patient with End-Stage Renal Disease on Intermittent Hemodialysis. Journal of Biosciences and Medicines, 14(05), 407-413. https://doi.org/10.4236/jbm.2026.145027
Vancouver
Stevens VM, Furnish CJ, Kiser TH. Betrixaban for Deep Venous Thrombosis Prevention in a Patient with End-Stage Renal Disease on Intermittent Hemodialysis. Journal of Biosciences and Medicines. 2026;14(05):407-413. doi:10.4236/jbm.2026.145027
BibTeX
@article{Stevens2026,
author = {Stevens, Victoria M and Furnish, Craig J and Kiser, Tyree H},
title = {Betrixaban for Deep Venous Thrombosis Prevention in a Patient with End-Stage Renal Disease on Intermittent Hemodialysis},
journal = {Journal of Biosciences and Medicines},
year = {2026},
volume = {14},
number = {05},
pages = {407--413},
doi = {10.4236/jbm.2026.145027}
}
EUVIMED